Literature DB >> 12411974

Eisenmenger's syndrome: current management.

Erika Berman Berman1, Robyn J Barst.   

Abstract

Eisenmenger's syndrome describes the elevation of pulmonary arterial pressure to the systemic level caused by increased pulmonary vascular resistance with reversal or bi-directional shunting through a large intracardiac or extracardiac congenital heart defect. This article reviews the natural history and pathophysiology of Eisenmenger's syndrome untreated and medical and surgical treatment options presently available. Although there is no cure for this condition at present, recent advances in management have improved the quality of life for many patients with Eisenmenger's syndrome. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411974     DOI: 10.1053/pcad.2002.127492

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  11 in total

Review 1.  Severe paediatric pulmonary hypertension: new management strategies.

Authors:  A Rashid; D Ivy
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

2.  An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease.

Authors:  Reda Ibrahim; John T Granton; Sanjay Mehta
Journal:  Can Respir J       Date:  2006 Nov-Dec       Impact factor: 2.409

3.  Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect.

Authors:  M D'Alto; C D Vizza; E Romeo; R Badagliacca; G Santoro; R Poscia; B Sarubbi; M Mancone; P Argiento; F Ferrante; M G Russo; F Fedele; R Calabrò
Journal:  Heart       Date:  2006-11-29       Impact factor: 5.994

Review 4.  Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review.

Authors:  N Fine; B Dias; G Shoemaker; S Mehta
Journal:  Can J Cardiol       Date:  2009-03       Impact factor: 5.223

Review 5.  Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.

Authors:  Nazzareno Galie; Alessandra Manes; Massimiliano Palazzini; Luca Negro; Alessandro Marinelli; Simona Gambetti; Elisabetta Mariucci; Andrea Donti; Angelo Branzi; Fernando M Picchio
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Clinical classification in pediatric pulmonary arterial hypertension associated with congenital heart disease.

Authors:  Willemijn M H Zijlstra; Johannes M Douwes; Mark-Jan Ploegstra; Usha Krishnan; Marcus T R Roofthooft; Hans L Hillege; D Dunbar Ivy; Erika B Rosenzweig; Rolf M F Berger
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

7.  A New Era in Medical Management of Severe Pediatric Pulmonary Arterial Hypertension.

Authors:  Dunbar Ivy; Ben T Saji
Journal:  Nihon Shoni Junkanki Gakkai Zasshi       Date:  2010-06-04

Review 8.  Etiology, diagnosis, and pharmacologic treatment of pediatric pulmonary hypertension.

Authors:  Robert Tulloh
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

9.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

10.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension in children.

Authors:  Maha Al Dabbagh; Hanna Banjar; Nasser Galal; Amjad Kouatli; Hammam Kandil; May Chehab
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.